SCHEMBL21156134

SCHEMBL21156134

CCOC(=O)c1cc2c(-c3ccc(OC)cc3)ccn2c(C(C)=O)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 6/20 0.47
GAA P10253 3/20 0.47
POLB P06746 2/20 0.47
HTT P42858 2/20 0.47
FNTA P49354 3/20 0.41
FNTB P49356 3/20 0.41
MAPT P10636 4/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
TP53 P04637 3/20 0.41
HPGD P15428 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19964421 0.89 SMARCA2 (0.51) KDM4EALDH1A1GAAPOLBHTT
SCHEMBL19964530 0.88 ALDH1A1 (0.46) KDM4EALDH1A1GAAFNTAFNTB
SCHEMBL21113331 0.86 SIRT2 (0.44) KDM4EALDH1A1GAAHTTMAPT
SCHEMBL21113045 0.82 ALDH1A1 (0.40) KDM4EALDH1A1GAAMAPTNPC1
SCHEMBL19964958 0.82 LMNA (0.45) KDM4EALDH1A1GAAPOLBHTT
SCHEMBL19964974 0.80 KDM4E (0.44) KDM4EALDH1A1GAAPOLBMAPT
SCHEMBL21113365 0.79 ALDH1A1 (0.37) KDM4EALDH1A1GAAMAPTNPC1
SCHEMBL21113050 0.79 ALDH1A1 (0.41) KDM4EALDH1A1GAAPOLBHTT
SCHEMBL19964413 0.78 KDM4E (0.48) KDM4EALDH1A1GAAPOLBFNTA
SCHEMBL21342364 0.78 EZH2 (0.45) KDM4EALDH1A1GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 KDM4E 52/4885ALDH1A1 2816/4885GAA 4565/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 KDM4E 52/4885ALDH1A1 2816/4885GAA 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.